During the past decade, Oncology Hematology Associates of Central Illinois, PC - Peoria conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 145 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 37 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncology Hematology Associates of Central Illinois, PC - Peoria" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 90 trials, followed by "National Cancer Institute (NCI)" with 56 trials sponsored, "SWOG Cancer Research Network" with 21 trials sponsored, "University of Chicago" with 16 trials sponsored and "Eastern Cooperative Oncology Group" with 16 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Hematology Associates of Central Illinois, PC - Peoria" #1 collaborator was "National Cancer Institute (NCI)" with 182 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "NCIC Clinical Trials Group" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator and "Eastern Cooperative Oncology Group" with 10 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Hematology Associates of Central Illinois, PC - Peoria" are "Breast Cancer" (41 trials), "Lung Cancer" (24 trials), "Lymphoma" (19 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (12 trials) and "Colorectal Cancer" (11 trials). Many other conditions were trialed in "Oncology Hematology Associates of Central Illinois, PC - Peoria" in a lesser frequency.

Most popular intervention types in "Oncology Hematology Associates of Central Illinois, PC - Peoria" are "Drug" (216 trials), "Other" (94 trials), "Biological" (80 trials), "Radiation" (40 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (38 trials), "placebo" (35 trials), "carboplatin" (18 trials), "Bevacizumab" (17 trials) and "Paclitaxel" (15 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Hematology Associates of Central Illinois, PC - Peoria" are 201 trials for "All" genders, 43 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Oncology Hematology Associates of Central Illinois, PC - Peoria". undefined are not yet recruiting, 1 are recruiting, 51 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 182 completed trials in Oncology Hematology Associates of Central Illinois, PC - Peoria, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Hematology Associates of Central Illinois, PC - Peoria, 16 "Phase 1" clinical trials were conducted, 127 "Phase 2" clinical trials and 110 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".